Brain iron levels in Parkinson’s disease by postmortem and MRI measurements: A systematic review and meta-analysis
Objective: In this study we performed a systematic review and meta-analysis aiming to understand PD-associated iron variations in all brain regions that have been examined,…Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease
Objective: To explore the relation between the non-motor symptoms (NMS) of PD and the involvement of brainstem through studying VEMPs. Background: Degeneration of several brainstem…Cerebellar GABA-A receptor activity is inversely correlated with gait speed in Parkinson’s disease
Objective: To investigate the relationship between regional cerebral expression of benzodiazepine receptors and gait speed in Parkinson's disease (PD). Background: Flumazenil is a short-acting intravenously…The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease
Objective: To evaluate the positions of the conus medullaris in patients with Parkinson's disease(PD). To know the prevalence of isolated lipoma of filum terminale(LFT) in…What predicts Parkinson’s disease? Hyposmia, MIBG SPECT, DAT SPECT and the PD-specific metabolic pattern
Objective: To compare dopaminergic imaging, cardiac sympathetic denervation, olfactory function and expression of a PD-specific metabolic cerebral pattern in patients with idiopathic REM sleep behavior…Detecting brainstem changes in Parkinson’s disease using quantitative MRI
Objective: 1. Can brainstem changes be detected using quantitative MRI (qMRI). 2. How many subjects would be required to detecting changes in brainstem regions affected…Substantia nigra hyperechogenicity in Mexican patients with Parkinson’s disease
Objective: To determine the prevalence of increased echogenicity in the substantia nigra in patients diagnosed with idiopathic Parkinson's disease at the University Hospital "Dr. José…MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study
Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…Neuropsychological assessment in a cohort of patients with Parkinson’s disease
Objective: To evaluate the cognitive profile in a cohort of patients with Parkinson's disease (PD) using a standardised battery. Background: Cognitive impairment is a great…Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment
Objective: Our aim is to assess CSF levels of amyloid-β1-42 (Aβ1-42), T-Tau, threonine-181 phosphorilated tau (P-Tau) and α-synuclein (α-syn) as well as different ratios of…
- « Previous Page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- …
- 207
- Next Page »